Sodium-Glucose Cotransporter 2 Inhibitors in Kidney Diseases Other Than That Due to Diabetes: Benefits in Composite Renal Outcomes Driven by Immunoglobulin A Nephropathy.
Roy, Subhankar, Madhurima Basu, Pradip Mukhopadhyay, and Sujoy Ghosh. 2026. “Sodium-Glucose Cotransporter 2 Inhibitors in Kidney Diseases Other Than That Due to Diabetes: Benefits in Composite Renal Outcomes Driven by Immunoglobulin A Nephropathy.”. The Journal of the Association of Physicians of India 74 (4): e1-e5.